Ted DeZabala, Deloitte & Touche LLP, United States
Advertisement
Articles by Ted DeZabala, Deloitte & Touche LLP, United States
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How the US Section 301 Probe Targets Germany's Drug Pricing
2
Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?
3
How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure
4
Payers Want Real-World Evidence. Why Aren't They Using It?
5